Menta Capital’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Menta Capital’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-12,377	Closed	-$160K	–	857
2014 Q4	$160K	Sell	12,377 -16,800	-58%	-$210K	0.02%	617
2014 Q3	$358K	Buy	29,177 +14,300	+96%	+$166K	0.06%	437
2014 Q2	$235K	Buy	+14,877	New	+$212K	0.04%	440

Other funds holding HZNP

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

TCP

Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Menta Capital's HZNP Position: Q1 2015 in Review

Menta Capital sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2015, closing a stake of 12,377 shares — an estimated $160K sold.

Menta Capital first reported a position in HZNP in Q2 2014 and held it in 3 quarters. The position peaked at $358K in Q3 2014. 177 funds tracked by Wall St. Rank hold HZNP as of Q1 2015.

Menta Capital reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2015 after selling out during the quarter.
Menta Capital sold 12,377 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2015, an estimated $160K.
Menta Capital first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2014 and held it in 3 quarters.
Menta Capital's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $358K in Q3 2014.
177 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2015.

Based on Menta Capital's 13F filing for Q1 2015, filed 24 Apr 2015.